tiprankstipranks
Trending News
More News >
BeOne Medicines (ONC)
NASDAQ:ONC
US Market

BeOne Medicines (ONC) Income Statement

Compare
783 Followers

BeOne Medicines Income Statement

Last quarter (Q1 2025), BeOne Medicines's total revenue was $1.12B, an increase of 48.64% from the same quarter last year. In Q1, BeOne Medicines's net income was $1.27M. See BeOne Medicines’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 3.81B$ 2.46B$ 1.42B$ 1.18B$ 308.87M
Gross Profit
$ 3.22B$ 2.08B$ -511.06M$ -447.86M$ -1.06B
Operating Expenses
$ 3.78B$ 3.29B$ 1.28B$ 990.87M$ 601.02M
Depreciation and Amortization
$ 171.76M$ 87.67M$ 66.28M$ 46.46M$ 31.79M
EBITDA
$ -396.44M$ -1.12B$ -1.72B$ -1.39B$ -1.63B
Operating Income
$ -568.20M$ -1.21B$ -1.79B$ -1.44B$ -1.66B
Other Income/Expenses
$ 35.20M$ 381.90M$ -171.37M$ 147.00K$ 39.49M
Pretax Income
$ -533.00M$ -825.84M$ -1.96B$ -1.44B$ -1.62B
Net Income
$ -644.79M$ -881.71M$ -2.00B$ -1.41B$ -1.60B
Per Share Metrics
Basic EPS
$ -6.12$ -8.45$ -19.37$ -15.21$ -19.11
Diluted EPS
$ -6.12$ -8.45$ -19.37$ -15.21$ -19.11
Weighted Average Shares Outstanding
105.29M 104.39M 103.13M 92.79M 83.47M
Weighted Average Shares Outstanding (Diluted)
105.29M 104.39M 103.13M 92.79M 83.47M
Currency in USD

BeOne Medicines Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis